Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1985): Schifter S+, Lancet 2, 499 (8%)
(1984): Odio C+, Am J Dis Child 138, 17
(1984): Rimailho A+, Presse Med (French) 13, 567
Exfoliative dermatitis
(1990): Forrence EA+, Drug Intell Clin Pharm 24, 369
(1988): Gutfeld MB+, Drug Intell Clin Pharm 22, 881
(1988): Neal D+, BMJ 296, 137
Fixed eruption
(2004): Gilmore ES+, Pediatr Dermatol 21(5), 600
Linear IgA dermatosis
(2006): Coelho S+, Int J Dermatol 45(8), 995
(2006): Navi D+, Dermatol Online J 12(5), 12
(2005): Onodera H+, JDermatol32(9), 759
(2004): Armstrong AW+, JCutanPathol31(5), 393
(2004): Jones DH+, J Am Osteopath Assoc 104(4), 157
(2004): Joshi S+, Ann Allergy Asthma Immunol 93(1), 101
(2004): Solky BA+, Cutis 73(1), 65
(2004): Waldman MA+, Clin Exp Dermatol 29(6), 633
(2003): Avci O+, JAmAcadDermatol48(2), 299 (passim)
(2003): Brinkmeier T+, J Dtsch Dermatol Ges 1(3), 212
(2003): Dellavalle RP+, JAmAcadDermatol48(5), S56
(2003): Lesueur A+, Presse Med 32(23), 1078
(2003): Montagnac R+, Nephrologie 24(6), 287
(2002): Cohen LM+, JAmAcadDermatol46(2), S32
(2002): Neughebauer BI+, Am J Med Sci 323(5), 273
(2002): Rocha JL+, Braz J Infect Dis 6(4), 196
(2001): Ahkami R+, Cutis 67, 423
(2001): Chang A+, Arch Dermatol 137, 815
(2001): Palmer RA+, Br J Dermatol 145(5), 816 (2 cases)
(2001): Wiadrowski TP+, Austral J Dermatol 42, 196 (with
ciprofloxacin)
(2000): Klein PA+, JAmAcadDermatol42, 316
(2000): Mofid MZ+, J Burn Care Rehabil 21(3), 246 (with
phenytoin)
(1999): Nousari HC+, Medicine 78, 1
(1998): Bernstein EF+, AnnInternMed129, 508
(1998): Nousari HC+, AnnInternMed129, 507
(1997): Norland A, Minneapolis, American Academy of
Dermatology Meeting (SF) (Gross and Microscopic)
(1996): Bitman LM+, Arch Dermatol 1289
(1996): Primka E+, JCutanPathol58
(1996): Tranvan A+, JAmAcadDermatol865
(1996): Whitworth JM+, JAmAcadDermatol890
(1995): Geissmann C+, JAmAcadDermatol296
(1995): Richards S+, Arch Dermatol 1447
(1994): Kuechle MK+, JAmAcadDermatol187
(1994): Piketty C+, Br J Dermatol 130
(1992): Carpenter S+, JAmAcadDermatol45
(1988): Baden LA+, Arch Dermatol 1186
Lupus erythematosus
(1993): Ena J+, JAMA 269, 598
(1986): Markman M+, South Med J 79, 382
Necrotizing vasculitis
(2002): Rocha JL+, Braz J Infect Dis 6(4), 196
Photoallergic reaction
(2001): Zabawski E, Longview, TX (from Internet) (observation)
Pruritus
(2004): Spencer L, Crawfordsville, IN (with daptomycin) (from
Internet) (observation)
(1991): Killian AD+, AnnInternMed115, 410
(1991): McCullough JM+, Drug Intell Clin Pharm 25, 1326
(1989): Koestner B+, Schweiz Med Wochenschr (German)
119, 28
(1986): Davis RL+, AnnInternMed104, 285
Purpura
(1998): Michael S+, Scand J Rheumatol 27, 233
Rash (sic)
(2001): Hsu SI, Pharmacotherapy 21(10), 1233
(1998): Elting LS+, Cancer 83(12), 2597 (11%)
(1997): Reis AG+, Rev Paul Med 115, 1452
VANCOMYCIN 569
(1993): Ena J+, JAMA 269, 598
(1983): Farber BF+, Antimicrob Agents Chemother 23, 138
Red man syndrome*(1–14%)
(2005): Mitchell D, Thomasville, GA (from Internet)
(observation)
(2004): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(2002): Cohen E+, J Antimicrob Chemother 49(1), 155 (10–14%)
(2002): Hui YL+, Acta Anaesthesiol Sin 40(3), 149
(2002): Rocha JL+, Braz J Infect Dis 6(4), 196
(2001): Wazny LD+, Ann Pharmacother 35(11), 1458
(2000): Wood MJ, JChemother12, 21
(1999): Khurana C+, Postgrad Med J 75, 41
(1998): Polk RE, Ann Pharmacother 32, 840
(1998): Wilson AP, Int J Antimicrob Agents 10(2), 143
(1997): Kralovicova K+, JChemother9(6), 420
(1996): Szymusiak-Mutnick BA+, Am J Health Syst Pharm
53, 2098
(1995): Lilley LL+, Am J Nurs 95, 14
(1994): Bergeron L+, Ann Pharmacother 28, 581
(1993): Ena J+, JAMA 269, 598
(1993): O’Sullivan TL+, JInfectDis168, 773
(1993): Polk RE+, Antimicrob Agents Chemother 37, 2139
(1992): Levy M+, Harefuah (Hebrew) 122, 36
(1992): Rengo C+, Recenti Prog Med (Italian) 83, 726
(1991): Killian AD+, AnnInternMed115, 410
(1991): Maccabruni A+, Recenti Prog Med (Italian) 82, 17
(1991): Valero R+, J Cardiothorac Vasc Anesth 5, 574
(1991): Wallace MR+, JInfectDis164, 1180
(1990): Bailie GR+, Clin Pharm 9, 671
(1990): Healey DP+, Antimicrob Agents Chemother 34, 550
(1990): Levy M+, Pediatrics 86, 572
(1990): No Author, Lancet 335, 1006
(1990): Sahai J+, Antimicrob Agents Chemother 34, 765
(1989): Pearson DA, J Am Dent Assoc 118, 59
(1989): Sahai J+, JInfectDis160, 876
(1988): Polk RE+, JInfectDis157, 502
(1988): Rubin M+, AnnInternMed108, 30 (3%)
(1987): Duro JC+, Med Clin (Barc) (Spanish) 89, 218
(1986): Daly BM+, Drug Intell Clin Pharm 20, 986
(1986): Davis RL+, AnnInternMed104, 285
(1986): Rolston KV+, JAMA 255, 2445
(1986): Wade TP+, Arch Surg 121, 859
(1985): Cole DR+, Lancet 2, 280
(1985): Garrelts JC+, NEnglJMed312, 245
(1985): Holliman R, Lancet 1, 1399
Red neck syndrome
(1985): Ackerman BH+, AnnInternMed102, 723
(1985): Pau AK+, NEnglJMed313, 756
Stevens–Johnson syndrome (